Protein kinase C subspecies in estrogen receptor-positive and -negative human breast cancer cell lines.
Estrogen receptor-positive (MCF7) and -negative (BT20) human breast cancer cell lines, which are frequently used for studies on cancer chemotherapy with triphenylethylene (TPE) anti-estrogens, express at least three protein kinase C subspecies. Two of them are identified as type II PKC having the beta-sequence and type III PKC having the alpha-sequence. The other one shows typical characteristics of PKC which responds to Ca2+, phosphatidylserine and diacylglycerol, but shows kinetic properties subtly different from the previously known PKC subspecies. Immunoblot analysis has shown that this enzyme does not correspond to any of the well defined subspecies with known sequence structures. All of these PKC subspecies are similarly susceptible to the TPE antiestrogens.
Bignon
E
E
Department of Biochemistry, Kobe University School of Medicine, Japan.
Ogita
K
K
Kishimoto
A
A
Nishizuka
Y
Y
D014408:Biomarkers, Tumor / Q000032:analysis*; D001943:Breast Neoplasms / Q000737:chemistry / Q000201:enzymology*; D002118:Calcium / Q000494:pharmacology; D002460:Cell Line; D002852:Chromatography, Ion Exchange; D004789:Enzyme Activation; D005260:Female; D006801:Humans; D007527:Isoenzymes / Q000302:isolation & purification / Q000378:metabolism*; D007700:Kinetics; D011493:Protein Kinase C / Q000302:isolation & purification / Q000378:metabolism*; D011960:Receptors, Estrogen / Q000032:analysis*; D013347:Subcellular Fractions / Q000737:chemistry / Q000201:enzymology; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology
D014408:Biomarkers, Tumor; D007527:Isoenzymes; D011960:Receptors, Estrogen; D011493:Protein Kinase C; D013755:Tetradecanoylphorbol Acetate; D002118:Calcium